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EXECUTIVE SUMMARY

The Population Council has embarked on a three-year
project to explore the acceptability of the progesterone vaginal ring (PVR) among women in sub-Saharan
Africa and the process for its potential introduction.
From February to May 2012, assessments were
undertaken in study countries in sub-Saharan Africa—
Kenya, Nigeria, and Senegal—to map the existing
landscape of family planning programs and new contraceptive technologies in an effort to identify national
priorities and assess the level of interest in the PVR
among stakeholders and to design appropriate preintroductory activities.
Research teams employed three approaches to
develop each country report: (1) a review of available
data; (2) a desk review of documents, project reports,
and policy guidelines; and (3) key informant interviews. Interviews were held with representatives of
key government, regulatory, and development agencies; social marketing organizations; research institutions; advocacy groups; private sector stakeholders;
policymakers; and civil society members.
This country mapping exercise confirms that Senegal is a promising context for the introduction of the
PVR. The government is committed to repositioning
family planning and has created an enabling environment. There are also various encouraging sociocultural trends which suggest potential for acceptance
of the PVR, including the fact that birth spacing is
already an accepted norm in Senegal.

Based on the information gathered, input from the
stakeholder interviews, and previous experiences of
contraceptive introduction, some key accompanying measures will need to be taken to ensure proper
execution of the acceptability study and subsequent
introductory efforts, including involving the Ministry of
Health early, developing and disseminating literature
on the PVR and project in French, and establishing an
appropriate communication plan to name a few.
Interviewees emphasized that the PVR must be an
integral part of the national family planning program.
Therefore, social resistance and perceived religious
barriers to use must be taken into account in the acceptability study and future possible introduction of
the PVR.
The PVR has the capability of improving family planning practices of postpartum women across diverse
spatial, demographic, and socioeconomic settings. By
extension, women’s use of the ring can improve the
health of her whole family. Its innovative, long- and
mid-acting, user-controlled design will introduce a
unique dimension to the current method mix and is
a promising prospect for provision at the community
level in Senegal.
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INTRODUCTION

.

While progress made in recent decades in fertility
reduction has been impressive, still up to 222 million
women in the developing world report an unmet need
for contraception (Singh and Darroch 2012). Part of the
challenge of addressing current levels of unmet need is
the limited use of contraception by women during the
first six to 12 months postpartum and the discontinuation rates of about half of all users abandoning their
methods six months after adopting them. Both issues
lead to limited success in effective birth spacing, which
can then negatively impact maternal and infant health.
New contraceptive methods are needed that offer
greater ease of use, are women-controlled, and do not
require significant health infrastructure or medical provider involvement for service delivery. One such method
is the progesterone vaginal ring (PVR), a user-controlled
contraceptive that, according to clinical trial data, is
safe and effective for breastfeeding women.
The Population Council has embarked on a threeyear project to explore the acceptability of the PVR
among women in sub-Saharan Africa and the process
for its potential introduction. From February to May
2012, assessments were undertaken in proposed project countries in sub-Saharan Africa—Kenya, Nigeria,
and Senegal—to map the existing landscape of family
planning programs and new contraceptive technologies
in order to identify national priorities and assess the
level of interest among stakeholders in the PVR and to
design appropriate pre-introductory activities. In Senegal, the research team employed three approaches to
develop the country report: a review of available data;
a desk review of documents, project reports, and policy
guidelines; and key informant interviews. Interviews
were held with representatives of key government,
regulatory, and development agencies; social marketing organizations; research institutions; advocacy
groups; private sector stakeholders; policymakers; and
civil society members. The report begins by describing the country’s demographics and fertility rates, and
then provides an overview of the health systems before
elaborating on the reproductive health policy context
with an emphasis on family planning policy and programs. Finally, the report explores potential support to
PVR as a new contraceptive option that could be added
to the method mix of the country’s national family planning program.

DEMOGRAPHIC PROFILE
According to the Agence Nationale de la Statistique et
de la Démographie (ANSD 2012), the projected population of Senegal in 2012 is over 13.2 million people. This
represents a near doubling of the population within 25
years; in 1988, the population was 6.9 million (ANSD
2005). The urban population accounts for nearly 42%
of total population. The Dakar region, which only covers

DEMOGRAPHIC SNAPSHOT
Population: 13.2 million
Growth rate: 2.5%
Total fertility rate: 5 children per woman
Contraceptive
	prevalence rate: 12%
Unmet need for FP
	for married women: 29%
Maternal
	mortality ratio: 392/100,000
Infant
	mortality rate: 47/1,000
Births occurring
withIN 24 months
	after prior birth: 18%
HIV INCIDENCE: 0.7%
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0.3% of the country, includes 23% of the total population (75% of the urban population). With a growth rate of
approximately 2.5% per year, the share of young people
in Senegal’s population is still growing; as of 2011, over
half of the population was under the age of 20. This can
be attributed to long-sustained high rates of fertility due
to low use of contraceptive methods (12% for women in
union), and a steady decline in infant mortality. The total
fertility rate (TFR) is currently 5 children per woman (at
an average of 6 per woman in rural areas, and 3.9 per
woman in urban areas), and the infant mortality rate
dropped from 68% in 1997–1998 to 47% in 2010–
2011 (ANSD and ICF International 2012).
Fertility rates in Senegal have been on the decline
since the first Demographic and Health Survey (DHS)
was taken in 1986, dropping from 6.4 children per woman in 1986 to 5.0 children per woman in 2010–2011.
Figure 1 presents the downward trend of the TFR over
time. However, clear differences appear between fertility rates for different socioeconomic groups of women.
For example, women in urban areas have a TFR of 3.9
compared to 6.0 for rural women. Educated women have
2.9 children on average compared to 5.8 for women with
no education. Also, women in the richest quintile have a
TFR twice as small as their counterparts in the poorest
quintile (3.3 vs. 7.0) (ANSD and ICF International 2012).
High fertility rates are explained in part by the
common practice of early marriage, which results in
early entry into sexual and reproductive activity. The
2010–2011 Demographic and Health Survey-Multiple
Indicator Cluster Survey (DHS-MICS) indicated that
two in three women and four in 10 men were married.

Sixteen percent of Senegalese girls are married by the
age of 15, with 40% married by the age of 18. Girls from
the poorest or rural households generally marry earlier
(at median ages of 16.5 and 17.7, respectively) and girls
from the richest or urban households tend to marry later
(23.2 and 21.5, respectively). The median age at first
marriage is 19.3 years for women. The median age at
sexual onset is 20.5 years for urban women and 17.5
years for rural women. Furthermore, 35% of married
women were in polygamous marriages, although the
practice is more common in rural areas.
Despite the fact that the median age at first birth
for females is 21 years old, 16% of female DHS-MICS
respondents aged 15–19 were already mothers, and
3% were pregnant with their first child. The high proportion of teenage mothers is even more dramatic in rural
areas—25%, as compared with 12% in urban areas.
TFR decreases with increased education level (Figure
2). However, although significant efforts have been
made in the field of education, schooling levels remain
low for both males and females. Fifty-eight percent of
women and 39% of men reported having had no formal
education. Furthermore, only 3% of female and 6% of
male respondents had actually completed secondary
education or higher.
Given the large population of uneducated Senegalese and the high prevalence of marriage (66% of
women of reproductive age are married), it is all the
more critical that easy-to-use, safe, and effective family
planning methods be made more accessible in Senegal.
One of the many developmental challenges associated with the dual problem of early marriage and lack
of female education is that, consequently, Senegalese

Figure 1: TOTAL FERTILITY RATE

Percent

Figure 2: TFR BY EDUCATION

Source: ANSD. 2012. Senegal 2010-2011 DHS-MICS. Final report
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Source: ANSD. 2012. Senegal 2010-2011 DHS-MICS. Final report

women often lack the ability to negotiate safe sex within
their marriages, including the use of modern contraception methods. This decreases the chances that a
woman can practice postpartum family planning in
order to space her pregnancies.
Interestingly, the median birth interval in Senegal is
34 months, which is generally considered to be healthy
spacing (although the WHO recommends spacing of
3–5 years). However, this figure does not reveal the
wide range of intervals experienced; countrywide, 18%
of infants were born fewer than two years after the previous birth. With an estimated maternal mortality rate
of 392 per 100,000 live births for the 10-year period
before the 2010–2011 DHS-MICS, the promotion of
postpartum family planning to prevent maternal death
due to closely-spaced births is an important avenue for
improving the health of women and infants in Senegal.

HEALTH SYSTEMS
OVERVIEW
The provision of reproductive health (RH) services within
the national health system in Senegal is hierarchically
based on the following four levels:
• Primary (community) level: health huts and health
posts;
• Secondary (district) level: health centers;
• Tertiary (regional) level: regional hospitals;
• National (central) level: referral hospitals and public
central administration.
All levels implement activities developed in the yearly
operation plan. However, specific responsibilities and
integrated packages of services are defined per level,
for example:
• The district level oversees planning as well as operationalization of the national policy and program with
the Service Delivery Points (SDPs).
• The regional level is charged with the coordination,
monitoring, and supervision of the national policy
implementation by districts. It also contributes to design, coordination, planning, and monitoring activities
at the regional level.
• The national level leads the design, coordination,
planning, and monitoring of national guidelines The
price for all commodities is also set at this level.

Except for health huts, services at each level of the
hierarchy are provided by doctors, nurses and midwives.
Health huts are equipped with community health workers (matrons, Badien Gox, relais). The private sector
and NGOs play an important role in the provision of RH
services. In a district, all SDPs, regardless of sector,
respond to the district Head Medical Officer.
The government of Senegal has undertaken a policy
of decentralization of health services. This policy focuses on providing services that are accessible geographically and financially, and that are socio-culturally and
religiously acceptable. Among others, these activities
include : (1) increasing the number of SDPs; (2) providing a minimum package of reproductive health services
at health posts; and (3) adjusting the costs of services
with the standard of living of the population.
This policy also ensures support to regional level by:
(1) strengthening human resources and providers’ training; (2) transferring technical and managerial skills; (3)
increasing the accountability of stakeholders (including
at community level); and (4) supportive supervision.

FAMILY PLANNING AND
REPRODUCTIVE HEALTH
POLICY CONTEXT
The introduction of family planning into Senegal first
began in 1970 in the private sector at the “Croix Bleue’’
clinic followed in 1975 by local NGOs such as the
Senegalese Association for Family Welfare (ASBEF).
The commitment of public authorities in favor of family
planning began in the 1980s with the execution of two
major projects: the Family Health and Population Project
funded by USAID and the Family Welfare Project funded
by UNFPA.
Senegalese national authorities first adopted an
official Declaration of Population Policy (DPP) in 1988.
The policy aimed to reduce the population growth rate
and the number of children per women. Family planning
is the primary strategy outlined for achieving this objective. The objectives of this policy are to:
1. Reduce morbidity and mortality, particularly among
mothers and children by strengthening RH programs;
2. Reduce fertility rate and population growth rate;
3. Harmonize population growth with development
requirements; and
3

4.

Improve the integration of the population variable in
the formulation and implementation of macroeconomic policies and multi-sectoral strategies.

• Advocacy for FP resource mobilization and greater
involvement of the private sector;
• Implementation of an FP communications plan;

The DPP was updated in 1995 and again in 2005 in
order to align the policy with the international agenda for
the Millennium Development Goals (MDGs). The MDGcentric goals were reiterated and updated in several
subsequent policy documents, including the “Roadmap
for accelerating the multi-sectoral fight against maternal and neonatal mortality” Government of Senegal
and the Strategic Action Plan on Reproductive Health
2012–2015.

• Strengthening of services in the public sector by
improving logistics system (“push model”), recruiting
qualified staff, and supervising activities;

In addition to setting a favorable political environment, the government adopted the 2005 Law on Reproductive Health (Government of Senegal 2005) which
governs the activities within the RH program. The Law
also outlines various rights and requirements designed
to regulate the types and quality of RH health services,
including family planning.

Targeting women with unmet need for family planning has become a key strategy for increasing CPR.
The DSRSE has engaged in multiple initiatives over the
years, including: (1) task-shifting to enable head nurses
to provide long-acting methods (Jadelle and IUCDs) in
health posts, and (2) community-level introduction of the
oral contraceptive pill by matrons in health huts. These
initiatives will help diversify the supply of and improve
access to contraceptive methods all the way to the most
peripheral levels throughout the country. In addition,
during the next few years, efforts will be directed toward
increasing method mix by promoting new contraceptive
methods.

In 2012, the Ministry of Health elevated the office
in charge of public reproductive health activities in
Senegal to the Directorate of Reproductive Health and
Child Survival (DSRSE). The new Directorate developed a
Family Planning Action Plan for the period 2012–2015.
This ambitious plan states a goal of increasing CPR from
12% in 2012 to 27% by 2015. This goal will require the
recruitment of 350,000 new users of contraceptive
methods, with a contribution of 125,000 new clients
by the public sector, 100,000 new clients by the private
sector, and 125,000 new clients by the community level
(Government of Senegal 2006). Priority actions to operationalize the Action Plan will address:

“Broadening the range of
contraceptive methods is
an opportunity to recruit
potential clients who
have not been satisfied
with the method mix
currently available.”
—Official at the
Ministry of Health
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• Strengthening of services offered in the private sector; and
• Strengthening of community-level FP activities by
introducing new initiatives to further improve access
to FP services.

Environment Regarding Hormonal
Contraceptives and HIV Risk
A 2007 set of protocols released by the DSRSE, “Protocoles des services de santé de la Reproduction,” clarified that the department’s approach to the question of
hormonal contraceptive involvement with HIV risk is one
of alignment with WHO directives concerning the issue.
In accordance with WHO guidelines, protocols for
family planning service provision integrate STI and HIV/
AIDS services. During family planning counseling, providers are required to emphasize the need for users to
protect themselves against HIV and other STIs. For each
method, the provider must inform clients whether it can
protect them against HIV or STIs. Moreover, in order to
take into account the family planning needs of people
living with HIV/AIDS (PLWHA), the DSRSE and the HIV/
AIDS Division within the Ministry of Health are collaborating to introduce FP services in PLWHA outpatient
treatment centers.

Healthcare Utilization Patterns
Contraceptives (specifically hormonal-based methods)
are available to the public through nationally integrated
family planning and maternal and child health (MCH)
programs. That is, clients can obtain family planning
methods through either MCH or family planning clinics.
In Senegal, family planning is considered a major and
transversal intervention for improving maternal and
child health.
While the majority of users (83%) obtain their
contraceptive methods from public health facilities,
national policy orientation promotes the involvement of
private and nonprofit sectors as essential sources for
providing family planning at all levels. Twelve percent of
clients obtain services from private facilities, and the remainder obtain them from other sources (ANSD and ICF
International 2012). In most clinical settings, a combination of skilled providers (nurses, midwives, and doctors)
offer family planning services. Generally, initial family
planning counseling is offered by trained communitybased workers.

Contraceptive Use
It is evident that long-acting contraceptive methods
are highly underutilized in Senegal. As part of its plan
to revitalize use of modern contraceptive methods, the
DSRSE will work to ensure a broad range of contraceptive options, but will focus specifically on promoting longacting methods. According to the Family Planning Office
Manager of the DSRSE, the office is also seeking to
promote user-controlled methods which reduce the need
for systematic interventions of a health care provider, a
strategy which has been termed “demedicalisation” of
family planning service provision.
Although 90% of females and 93% of male respondents to the 2010–2011 DHS-MICS indicated knowledge of at least one modern method of family planning
(most commonly the oral contraceptive pill and male
condoms), usage remains relatively low (13% for married women) and unequally distributed across socioeconomic groups (see Figure 3).
The low usage is at odds with the declared family
planning desires of women: 21% of married women do
not want any more children, and 38% want to wait at
least two years before their next birth (ANSD and ICF
International 2012).4 Overall, unmet need for family
planning among currently married women is nearly 30%,
a rate that varies little between rural and urban areas

Figure 3: CURRENT USE OF FAMILY PLANNING
BY MARRIED WOMEN

Source: Senegal 2010-2011 DHS-MICS. Key findings.

(29% vs. 30%, respectively).4 A survey conducted by
the Senegal Urban Health Initiative (ISSU) across four
urban centers indicated similar findings between income
groups (http://www.urbanreproductivehealth.org/sites/
mle/files/Data_Handout_French_0.pdf).
The most common contraceptive methods offered
by the National Program are oral contraceptive pills,
injectables, male and female condoms, the IUCD, and
the implant ). In the 2010–2011 DHS-MICS, the most
common methods actually used by women, however,
are pills (2.9%) and injectables (3.7%) in all places of
residence, though in different proportions. In urban settings the pill is used by 7.5% of women and injectables
are used by 7.7%, whereas in rural areas the pill is used
by 1.7% of women and injectables are used by 3.5%. As
shown on Figure 4, the survey conducted by ISSU also
found pills and injectables to be the most commonly
used methods in the 4 urban sites. It also indicated

Figure 4: MODERN FAMILY PLANNING
METHOD MIX
Injectables
34%

Pill
37%

Other
modern
method
5%
Condom
10%

IUD
6%
Implants
8%

Source: ISSU, MLE and IntraHealth survey in four urban centers.
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that there was more demand for long-acting methods
(Jadelle at 8% and IUCDs at 6%) in these urban settings
than at the national level.
Until recently, women preferred injectables or the
pill because they are easy to conceal, easy to use, and
appropriate for facilitating the local norm of two-year
birth spacing. Providers themselves often preferred
providing these methods because they are less demanding in terms of work time and resource mobilization.
Additionally, until recently, long-acting methods were
not available at health posts. However, recent efforts for
repositioning FP with a focus on longer acting methods
seem to lead to a preference shift toward methods such
as Jadelle (five years).
In 2000, emergency contraception (EC) was introduced into the national family planning program in both
the private and the public sector. This effort, conducted
by the DSRSE with support from the Population Council,
led to the full integration of EC into national guidelines.
However, EC usage remains low. From the demand
side, socio-cultural and religious barriers are the main
factors limiting its promotion and use. From the supply
side, service provider attitudes and practices are often
unfavorable toward delivering EC.

Social and Religious Influences
Various surveys explore the nature of family and community influences on contraceptive preferences, perceptions, and challenges to access (Intrahealth International 2012). For example, in the ISSU study, 18% of women
not utilizing modern contraception indicated that they
were either personally opposed to it, or believed that
their husbands were opposed to it. Fourteen percent
of female respondents feared potential side effects or
health problems with the use of modern contraception,
whereas nearly half of married male respondents believed that family planning is harmful to women’s health.
Ninety-four percent of Senegalese are Muslim while
4% are Christian and 2% animist. More than 90% of
male and female responses to the ISSU survey agreed
or strongly agreed that only God can decide the number
of children a couple will have. Collaboration with Muslim
and Christian networks has helped mitigate misinterpretation of the position of religion toward family planning. Furthermore, outreach activities undertaken by a
Muslim network contributed to clarifying women’s status
and rights within Islam and society, including with regard
to family planning. Also, over three-quarters of respon6

dents (79% of female and 74% of male respondents) felt
that religious leaders should speak more overtly about
the role of family planning in religion. But while it is
encouraging that the majority of male respondents indicated a willingness to hear more about family planning,
the fact remains that the social and economic position
of women in Senegal reduces their decisionmaking abilities regarding their reproductive health, even though
Senegalese law promotes their right to do so.

Adolescents
The 2005 RH law establishes the right of adolescents to
access quality family planning services. Yet most stakeholders indicate that young people are insufficiently
taken into account in the implementation of family planning programs even while the political and legal environments have improved. Cultural norms that prohibit sex
before marriage reinforce the stigma of adolescents
who want to use the services. In addition, despite
improved provider training, young people continue to be
stigmatized when attending health facilities. Moreover,
inadequate hours and high costs limit adolescents’ access to reproductive health services.
Some key stakeholders suggest that improving young
people’s access to services requires the following measures be taken:
• Implement suitable and appropriate channels of communication, including using Information & Communication Technologies (ICTs);
• Strengthen youth RH education;
• Broaden the network of youth counseling centers,
especially in rural areas; and
• Strengthen the capacity of providers to address the
needs of adolescents.

Stakeholders’ Suggestions
Stakeholders interviewed for this mapping exercise
emphasized that the PVR must be an integral part of the
national family planning program. Therefore, the following social resistance and perceived religious barriers to
use that are faced by the program must be taken into
account in the acceptability study and future possible
introduction of the PVR:
• Disseminate the law on RH;
• Involve men more in FP programs;

• Integrate FP into the package of services for women
and children victims of sexual violence;
• Disseminate religious discourses on the position of
Islam and Christianity on FP; and
• Increase the involvement of community actors and
journalists in communication about FP.

Postpartum Family
Planning: Norms and
Practices
The norm for birth spacing in Senegal is approximately
two years. However, it is important to note that while
birth spacing is encouraged, socio-cultural and religious
norms are not favorable to birth limitation, which may
contribute to the lack of widespread uptake of longacting methods. National family planning programs
themselves emphasize birth spacing over limitation as
well. Yet although this socio-cultural context is not one
that encourages birth limiting, the fact that any kind of
spacing between births is acceptable does suggest that
successful promotion of postpartum family planning
methods such as the PVR and increasing the norms for
birth intervals to 3–5 years may in fact be possible.

breastfeeding policies
and practices
Breastfeeding Practices
Breastfeeding is near universal in Senegal, with nearly
all (98%) children ever being breastfed. At 12–17
months of age, 95% of children are still breastfeeding,
although not exclusively. Seventy-one percent of children
aged 6–9 months receive complementary foods. The
norm for weaning is around two years (the median duration of breastfeeding being approximately 21 months).
Yet although Ministry guidelines promote early breastfeeding as a central component of essential neonatal
care, and national family planning programs have integrated lactational amenorrhea method (LAM) into their
range of promoted methods, only 48% of children are
breastfed in the first hour of life and 89% are breastfed
the day after birth. Further, the 2010–2011 DHS-MICS
revealed that 53% of newborns receive food other than
breast milk in the first three days after birth.

Breastfeeding in
Senegal
• 98% of children are
ever breastfed
• 39% of infants
(<6 months) are exclusively breastfed
• Norms for weaning: 2
years

Only 39% of children below six months of age are exclusively breastfed, due in part to a belief in the necessity of early supplementation of breast milk by other foods
in the newborn’s diet. Introduction of water is one of the
key inhibiting factors to strict breastfeeding as many
mothers continue to think that water is essential for
the child’s survival. Moreover, the practice of exclusive
breastfeeding is constraining for some women, especially working women and urban and educated women,
although labor laws contain provisions to help nursing
mothers adhere to the practice.

National Breastfeeding and Formula
Policy
The National Policy for Infant Feeding strongly recommends exclusive breastfeeding until 6 months of age.
Thus, the sale of breast milk substitutes for infants
younger that six months is prohibited by a ministerial
decree signed in 1994. This decree was aimed at health
workers, pharmacists, pharmaceutical companies,
manufacturers of breast milk substitutes, and manufacturers of mineral water. However, since its enactment,
the decree has not been enforced and is not being monitored by the Ministry of Commerce.
For children older than six months, the National
Policy promotes the effective implementation of the
International Code of Marketing of breast milk substitutes such as formula. This code (although it is not
effectively followed) aims to reinforce the accessibility
and availability of maternal milk substitute in public
and private SDPs including health posts, health centers,
and hospitals.
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SECURING CONTRACEPTIVE
COMMODITIES AND
GETTING THEM TO
MARKET
Commodity Procurement Process
To streamline the contraceptive supply chain, the Ministry of Health integrated contraceptives into the national
list of essential drugs. The current logistics system is
organized as follows:
• National Supply Pharmacy (PNA) that controls supply
of RH commodities at the national level, and transfer
of these products to the regional level
• Regional Supply Pharmacies (PRA)
• District depots
• Service Delivery Point (SDP) depots
The current supply system is set up as follows:
• SDPs send their orders to the district;
• The district aggregates these orders and sends a
global order to the regional level;
• The regional facility transmits the orders from all its
districts to the PNA.
Each level is responsible for planning for their commodity needs and orders are made quarterly. Monitoring
is ensured by the PNA which delivers products based on
the quarterly inventory records tracing the movements of
commodities.
The supply system is organized by level to prevent
shortages, reduce expiration, and establish coherent
contraceptive orders:
• At the PNA level; no more than 12 months and no fewer
than six months of supply must be stored at any time;
• At the PRA level, supply storage is permitted for a
maximum of six months and a minimum of three
months;
• At the district level, the maximum storage time allowed is four months and the minimum is one month;
• At the SDP level, supplies may be stored for one
month.
The prices of contraceptive products are set by the
government of Senegal, including profit margins, for
each level and sector.
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Although this system ensures effective integration
of FP products in the PNA system, it does have some
drawbacks, including restrictions on storing FP products
(since the PNA, PRAs, and districts have to store larger
quantities of contraceptives.) Moreover, delays are often
noted in the ordering of contraceptive products by the
SDPs because profits from the sale of the contraceptives
are used first to pay for the high SDP operating costs.
Limited options for postpartum family planning are
prominent among the numerous obstacles to widespread use of family planning in Nigeria.

Commodity Security Issues
In an effort to avoid supply chain difficulties and ensure the availability of contraceptive commodities for
family planning programs, DSRSE has implemented a
contraceptive security plan that focuses on: (1) capacitybuilding of logistics managers, (2) onsite training at
governmental depots; (3) training of managers in MOH
logistical management tools (Channel, Reality Check,
Optimize); and (4) supportive supervision. In addition,
the Informed Push Model was pilot tested with the collaboration of the ISSU project. This model rationalizes
contraceptive distribution and management from the
district to the regional level. Results from the pilot testing that took place in two districts (Pikine and Kaolack)
revealed a significant decrease in the rate of contraceptive stockout (0% stockout), and better management of
product ordering, which was facilitated by better data
reporting (100% of SDPs transmitted their data) . A scaling up of the model is planned by June 2013 in the three
following regions (Dakar, Kaolack, and Thiès) by Initiative
Sénégalaise de Santé Urbaine/Senegalese Urban Health
Initiative (ISSU), after which the experience will be extended to the rest of the country in accordance with the
National Action Plan for Family Planning implementation.
This plan also emphasizes the integration of contraceptives into the drug quality control process as well as into
a pharmaceutical supervision process (occurring on a
quarterly basis).

Regulatory Framework for New
Contraceptives and Health Products
The introduction of any new drug or product must
follow the procedures of the Directorate of Pharmacy
and Medicines (DPM). A permit and a Market Intro
duction Authorization (MIA) are required. To obtain
these approvals, specific documentation is required

on the product (specificity, safety, efficacy, characteristics, clinical trials, and results of acceptability
study). However, for research purposes, approval from
the National Ethics Committee for Health Research
(CNERS) is sufficient. The study protocol should include
information about the product (documentation of
previous studies on safety, efficacy, where the product
has been tested, findings of previous research, study
areas, necessary amount of product to be used in the
study). The approval from CNERS must be accompanied by a letter from the DSRSE addressed to the DPM
requesting authorization to introduce the product. This
procedure requires close monitoring on the part of the
research team to prevent potential delays. In addition,
customs clearance can be time-consuming and complex. Some stakeholders interviewed have suggested
hiring an import consultant specializing in these issues,
if necessary.

Experience of
Contraceptive
Introduction in
Senegal
The government of Senegal is keen to expand the range
of methods available to couples for achieving their
reproductive health goals. The multiple examples of
product introduction in the country can be considered
positive indicators that there is indeed interest for new
contraceptive products. Furthermore, both policymakers
and development partners are interested in the introduction of new contraceptive methods. Stakeholders
also show openness to new technologies, especially if
these technologies are consistent with national policies
and guidelines.

“A broader range of
methods will meet users’
need better, particularly
for women with unmet
need.”
—DEVELOPMENT PARTNER

Latest Contraceptive Methods in
Introduction
In the past few years and looking forward, several
methods have been/will be pilot tested or studied for
acceptability. Such experiences can serve as valuable
groundwork for planning the introduction of the PVR.
These include:
Introduction of Emergency Contraception (EC).
Since 2000, the Population Council has supported the
efforts of the Ministry of Health in the introduction of
EC into the national FP program. These efforts have
targeted both the public and private sectors and helped
to officially include EC products in the range of national
FP methods. EC products are now integrated into the
Policies, Standards, and Protocols of FP services. The

Latest contraceptive
methods in introduction
• Emergency contraception
• Depo Provera IM (DMPA IM)
at community level
• Acceptability of Depo-subQ
Provera (aka Sayana Press)
• Implanon
• PVR

private sector is the preferred source of provision of
EC because it offers privacy and is accessible to many
segments of the population, despite higher prices.
Meanwhile, supply through the public sector is low
due to insufficient promotion and frequent expiration
of products linked with slow demand. Furthermore,
research indicates negative attitudes of providers about
EC products, which do not favor their promotion. As a
manager at the national level indicated “low demand of
EC explains the expiry of 20,000 units of DUET bought
with the national budget’’ (Population Council 2012). In
addition, EC is poorly integrated into initial family planning counseling.
Administration of Depo Provera IM (DMPA IM) by
Community Health Workers: In 2012, the Ministry
of Health, with support from FHI360, Childfund, and
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CEFOREP, started pilot testing the introduction of DMPA
IM by Community Health Workers in three districts (Joal,
Dioffior, and Nioro) across three regions of Senegal. The
study will continue until March 2013.
Acceptability study of Depo-subQ Provera 104 in
the Uniject system (also known as Sayana Press): In
2012, the Ministry of Health began leading efforts for
the introduction of Depo-subQ Provera 104TM in the Uniject system to Senegal, with support from PATH, FHI360,
and CEFOREP (PATH 2012). The study has two components: an acceptability study and operations research.
Working in three districts of the Thiès region (Mbour,
Thiès, and Tivaouane), PATH leads the operations
research and FHI360 is in charge of the acceptability
studies. Enrollment for the acceptability study was completed at the end of 2012 for a three-month follow up.
TM

Introduction of Implanon: As part of FP repositioning,
the Ministry of Health is introducing Implanon. DSRSE
has received part of the products from UNFPA, to be
used for providers’ training. Providers from the Dakar
region were trained in 2012.

Lessons Learned from Experiences of
Contraceptive Introduction
Based on these previous experiences, there are several
key lessons learned:
• Early involvement of Ministry of Health Officials and
advocacy with policymakers is essential for facilitating product introduction and ensuring proper ownership by national stakeholders; recourse to the
contraceptive security technical committee offers an
opportunity to obtain validation from the MOH and
to contribute to their regular update during study
implementation.
• Continuous communication with decisionmakers is
useful in generating their support.
• It is important to foresee customs procedures to
avoid delays in introducing the product in the country. The research team will need to ensure that all
technical documents required for the approval are
available in a timely manner. Stakeholders consulted
strongly suggested that the firm that markets and
promotes the product, Andromaco, be associated
from the beginning to provide support and experience to the research team in the introductory phase.
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Several tasks should be implemented differently from
previous efforts to introduce new contraceptive products. Specifically, the Council must:
• Build sufficient time for national partners to provide
ethical and technical reviews so as to ensure that
introductory activities are conducted in a framework
of voluntarism, choice, and rights.
• Integrate into the preparatory phase of the study lessons learned from previous experiences on contraceptive products introduction in Senegal.
• Promote the PVR as soon as possible in health
services (such as at postnatal care, prenatal care,
immunization services and maternity wards) so that
women are familiar with it at the start of the study.
• Involve key stakeholders from the beginning.
Some of the resources that must be made available
include:
• Relevant French literature on PVR.
• Providers’ training in the use of PVR and management of side effects.
• Product documentation.

Support for the PVR
The government of Senegal has been a strong supporter of the idea of introducing the PVR into health programs. That the vaginal ring offers new user-controlled
opportunities for women would fit aptly into the political
repositioning of FP adopted by the Ministry of Health in
recent years.
This approach taken by the Ministry of Health is
strongly supported by the development partners. As one
of them indicated: “[The PVR] offers new opportunities
and options to women.” They also confirmed their willingness to support and collaborate with any project that
is in line with government policy.
However, some partners pointed to “the need to
respect the ethical rules that govern the provision of
contraception, particularly in the immediate postpartum
period” [a manager at the national level]. Communication efforts will be required to ensure that managers
at all levels of the health system understand the
method, how it fits in the current range of contraceptive methods available in Senegal, and when it can be
provided to a woman. Other stakeholders suggested
“anticipating supply problems that could arise from

providing a wider range of methods (e.g. storage) and
adjusting method mix to preferences by area” [a manager at the national level].
During consultation for the mapping exercise, several
stakeholders indicated a positive attitude toward the
PVR and believed that it could be introduced successfully in the mix of methods. Most stakeholders believed
that the PVR could rise prominently in the range of
contraceptive methods because of its innovative nature
and the fact that it is more easily administered in health
posts, as a method of family planning that requires minimal provider involvement. It could therefore be made
more accessible to rural women than other long-acting
methods which, until recently, were only available at
health centers and hospitals. Such continued decentralization of product delivery could have a significant
positive impact on current patterns of use.
Supportive stakeholders also raised several considerations:
• Possible reluctance about inserting the PVR into
the vagina for women who do not like to touch their
genitalia
• Husband’s attitude
• Interference of the ring during sex
• Possible effects of vaginal douche (a common practice in Senegal) on ring efficacy
• Ring operating mode
• Management of side effects
• Potential expulsion of the ring;
• Suitability of the ring to all women
Despite the large interest in this new method, there are
potential factors that could hinder PVR uptake, such as
conservative opinions, negative rumors about the PVR
and/or device-based modern contraception generally,
gender issues, and decision processes.

Sector of Introduction
According to most stakeholders interviewed, the PVR
could be introduced in both the public and private sectors. To achieve the goal of 27% prevalence rate targeted by the 2012–2015 Family Planning Action Plan,
125,000 of the 350,000 new clients to be recruited by
2015 will be enrolled by the public sector and 100,000
by the private sector. Some key stakeholders believe
that the vaginal ring is also suitable for community- level

introduction, with 125,000 new clients expected from
this level.

Communicating about the PVR
Eighty-eight percent of households in Senegal have
a mobile phone. Seventy-five percent own a radio,
and 79% of urban and 26% of rural households have
a television. However, in the months preceding the
2010–2011 DHS-MICS survey, 60% of female and
49% of male respondents did not see, hear, or read a
family planning message on the radio, television, or in
a magazine or newspaper. Among women not currently
using a contraceptive method, 89% did not discuss family planning with a health worker, and only 6% had been
visited by a fieldworker who discussed it. Among women
who visited a health facility in the last 12 months, only
7% had discussed family planning with a health worker
during their visit. This information clearly indicates that
improved methods of communication are required for
more women to become aware of and to utilize family
planning methods.
Several avenues of information could be useful for
developing and disseminating PVR messaging. An
approach based on social marketing focusing on customer needs could effectively highlight the advantages
of the product, such as efficacy, lack of interference
with sexuality and breastfeeding, and its being usercontrolled. A community-based approach to awarenessraising and product provision could also be developed.
On the whole, the integration of the PVR into the existing range of available contraceptive methods offered
during initial counseling is a preferred way of establishing it in the existing family planning product mix. In addition, many stakeholders suggested that a good communication strategy be developed to increase public
support for this product.

Conclusions
Senegal is a promising context for the introduction of the
PVR. The government is committed to repositioning family planning and has created an enabling environment,
with factors such as:
• The adoption of the 2005 Law on Reproductive
Health that contributes to creating a legal environment conducive to family planning program initiatives;
11

• The elaboration of a Strategic Plan for Reproductive
Health which is similarly conducive and involves the
private and nonprofit sectors as well as communitylevel actors as strategic sources for providing family
planning;
• The elaboration and high visibility launch of the
2012–2015 Family Planning Action Plan;
• An effective family planning advocacy effort, which
helps to mobilize public resources for the purchase of
contraceptives;
• The improvement of service delivery through training of
the majority of providers in contraceptive technologies;
• Task-shifting to head nurses, helping to strengthen
accessibility to long-acting contraceptive methods at
the peripheral level;
• The decentralization of service delivery at the community level, starting with the initial provision of oral
contraceptive pills by matrons in heath huts, and
current research on introduction of methods such as
Uniject IM and Depo SubQ at community level;
• The strengthening of the logistics system through
training of key staff in contraceptive logistics, supportive supervision, and testing of innovative approaches such as the Push Model; and
• Efforts to raise awareness of family planning at the
community level by working with community-based
organizations (Badien Gox, women’s groups, religious
networks).
There are also various encouraging socio-cultural trends
which suggest the potential for acceptance of the PVR,
including that:
• Birth spacing is already an accepted norm in Senegal,
indicating that the PVR’s status as a primarily postpartum family planning method could garner it more
support among the general population;
• Over three quarters of both male and female respondents felt that religious leaders should speak
more overtly about family planning.
However, based on the information gathered, input
from the stakeholder interviews, and previous experiences of contraceptive introduction, some key accompanying measures will need to be taken to ensure proper
execution of the acceptability study, including:
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• Involve officials of the Ministry of Health early and
thorough the process;
• Ensure that all documentation and paperwork required for the introduction of the product be completed before the research team engage introduction
procedures;
• Develop and disseminate literature on the PVR and
project in French as much as possible;
• Establish a strong and appropriate communication
plan; and
• Establish a timely procurement system.
To address social resistance and perceived religious
barriers to use of family planning, stakeholders indicate
that the following efforts should be made:
• Disseminate the law on RH;
• Involve more men in FP programs;
• Disseminate religious discourses on the position of
Islam and Christian on FP; and
• Increase the involvement of community actors and
journalists in communication about FP.
Some key stakeholders suggest that improving young
people’s access to services requires the following measures be taken:
• Implement suitable and appropriate channels of communication, including using ICTs;
• Strengthen youth RH education;
• Broaden the network of youth counseling centers,
especially in rural areas; and
• Strengthen the capacity of providers to address the
needs of this population.
The PVR has the capability of improving the family planning practices of postpartum women across a wide span
of spatial, demographic, and socioeconomic settings.
By extension, women’s use of the ring can improve the
health of her whole family. Its innovative, long-acting,
user-controlled design will introduce a unique dimension
to the currently available method mix and is a promising
prospect for provision at the community level. If the acceptability study and subsequent introduction of the PVR
are conducted with care and methodology, this method
has a strong chance for success in Senegal.

List of Stakeholders Interviewed

Institutions

Persons contacted

Title

Directorate of Reproductive Health
and Child Survival

Dr Bocar Daff
Dr Ousseynou Faye
Dr Fatima Ndiaye
Mme Aissatou Sano Coly
Dr Rokhaya Kandé

Director
Head of Maternal Health Division
Head of Logistics
Head of Family planning Division
Reproductive Health Administrator

CEFOREP
Childfund
FHI360/Progress

Dr Aissatou DIOP
Dr Serigne Momar Kane
Dr Balla Moussa Diedhiou
Mr Moussa Mané
Dr Binta Ndiaye
Mr Thierno Dieng
Mme Sébastiana Diatta
Dr Siga DIOP

IntraHealth
Marie Stopes International

Mme Hawa Talla
Dr Maaike Van Minke

Chief of Division
Director of Research
Executive Director
Program Director
Clinical Coordinator
Coordinator
Reproductive Health Advisor
Research Associate (Progress Project Administrator)
Program Coordinator
Country Director

PATH

Mme Colette Ndoye
Dr Yakou Dieye

Private Physician Association

Dr Manuel PINA

Religious Network (Islam)
Senegalese Midwives Association
Senegalese Urban Health Initiative
Project (ISSU)

Mr Ousmane Samb
Mme Marieme Fall
Dr Fanding Badji

Directorate of Pharmacy and Medicines
DANSE
ADEMAS
ASBEF

Siggil Jiggen Network
UNFPA
USAID

Mme Aminata Niang
Mme Fatou Ndiaye Turpin
Dr Selly Kane
Dr Amadou Mbow
Dr Ramatoulaye Dioum

Reproductive Health Advisor
Coordinator RH Program & M&E
Advisor
Private Physician, Association
Member
Program Coordinator
President
Deputy Administrator/ Services
Supply
Dakar City Coordinator
Program Coordinator
Reproductive Health Advisor
Reproductive Health Advisor
Reproductive Health Advisor

13

REFERENCES

ANSD (L’Agence Nationale de la Statistique and ICF International). 2012. 2010–11 Senegal Demographic and
Health and Multiple Indicators Survey: Key Findings.
Calverton, Maryland, USA: ANSD and ICF International.
Government of Senegal. 2012. Plan d’Action Nationale de
Planification Familiale. 2012-2015. Dakar: Government
of Senegal
———. 2006. “Roadmap for accelerating the multi-sectoral
fight against maternal and neonatal mortality, 2006–
2015.” Dakar: Government of Senegal.
———. 2005. “Loi no 2005-18 du 5 août 2005 relatif à
la santé de la reproduction.” Dakar: Government of
Senegal.
IntraHealth. July 2011. Maternal, Neonatal and Child
Health Program - Endline report.
Intrahealth International. 2012. “2011 Baseline Survey for
the Senegal Urban Health Initiative (ISSU) Household
Survey: Final Report.” Chapel Hill, NC.

14

ISSU, MLE, and IntraHealth. La planification familiale sauve des vies : initiative en sante santé de la reproduction en milieu urbain. <http://www.urbanreproductivehealth.org/sites/mle/files/Data_Handout_French_0.
pdf>.
PATH. 2012. Etude opérationnelle : logistique de l’administration de depo-subQ dans le système d’injection Uniject au Sénégal et en Ouganda. Seattle: PATH. <http://
www.urbanreproductivehealth.org/sites/mle/files/
depo_operational_assessment_factsheet_mars2012_
french_a4_27-feb.pdf>.
Population Council. 2012. “Key opinions leaders’ and providers’ attitudes, beliefs, and practices about EC.” New
York: Population Council.
Susheela Singh and Jacqueline E. Darroch. 2012. Adding it
up: Costs and Benefits for Contraceptive Services. New
York: Guttmacher, Institute and UNFPA.

